CircRNAs in anticancer drug resistance: recent advances and future potential

T Xu, M Wang, L Jiang, L Ma, L Wan, Q Chen, C Wei… - Molecular cancer, 2020 - Springer
CircRNAs are a novel class of RNA molecules with a unique closed continuous loop
structure. CircRNAs are abundant in eukaryotic cells, have unique stability and tissue …

Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology

RI Haddad, L Bischoff, D Ball, V Bernet… - Journal of the National …, 2022 - jnccn.org
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …

Evolving molecularly targeted therapies for advanced-stage thyroid cancers

KC Bible, M Ryder - Nature Reviews Clinical Oncology, 2016 - nature.com
Increased understanding of disease-specific molecular targets of therapy has led to the
regulatory approval of two drugs (vandetanib and cabozantinib) for the treatment of …

Anaplastic thyroid carcinoma, version 2.2015

RI Haddad, WM Lydiatt, DW Ball, NL Busaidy… - Journal of the National …, 2015 - jnccn.org
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were …

Anaplastic thyroid cancer cells induce the release of mitochondrial extracellular DNA traps by viable neutrophils

L Cristinziano, L Modestino, S Loffredo… - The Journal of …, 2020 - journals.aai.org
Neutrophils are key effector cells that orchestrate inflammatory responses in the tumor
microenvironment. Although neutrophil extracellular DNA traps (NETs) entrap and kill …

Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: outcomes from the National Cancer Data Base

TA Pezzi, ASR Mohamed, T Sheu, P Blanchard… - Cancer, 2017 - Wiley Online Library
BACKGROUND The outcomes of patients with unresected anaplastic thyroid carcinoma
(ATC) from the National Cancer Data Base (NCDB) were assessed, and potential …

An update of the appropriate treatment strategies in anaplastic thyroid cancer: a population‐based study of 735 patients

N Huang, X Shi, B Lei, W Wei, Z Lu, P Yu… - International Journal …, 2019 - Wiley Online Library
Background. Anaplastic thyroid cancer (ATC) responds poorly to conventional therapies and
requires a multidisciplinary approach to manage. The aim of the current study is to explore …

The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer

N Denaro, CL Nigro, EG Russi… - OncoTargets and …, 2013 - Taylor & Francis
Anaplastic thyroid cancer represents 1%–2% of thyroid cancers. For its aggressiveness, it is
considered a systemic disease at the time of diagnosis. Surgery remains the cornerstone of …

Treatment outcomes in anaplastic thyroid cancer

KL Corrigan, H Williamson… - Journal of Thyroid …, 2019 - Wiley Online Library
Background. Anaplastic thyroid cancer (ATC) is rare, accounting for 1‐2% of thyroid
malignancies. Median survival is only 3‐10 months, and the optimal therapeutic approach …

[HTML][HTML] Clinical trials in management of anaplastic thyroid carcinoma; progressions and set backs: a systematic review

B Salehian, SY Liem, HM Amiri… - International Journal of …, 2019 - ncbi.nlm.nih.gov
Methods A systematic review of studies from 1995 to 2017 was performed employing the
search terms “anaplastic thyroid” and “treatment” in PubMed. Studies comparing patients …